41 related articles for article (PubMed ID: 23303010)
1. Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion.
Lenskaya V; Yang RK; Cho WC
J Cutan Pathol; 2024 Jun; 51(6):419-423. PubMed ID: 38468567
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous apocrine carcinoma: A challenging case report.
Khessairi N; Fertani Y; Sakhri S; Abbess I; Zemni I; Dhiab TB
Int J Surg Case Rep; 2024 Apr; 117():109513. PubMed ID: 38518464
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous cribriform apocrine carcinoma: a dermatoscopic pitfall.
Astorino S; DI Nunno D; Monfrecola A; Ferrari A; Saponaro A; Catalano C; Troiani G; Laghi A
Ital J Dermatol Venerol; 2024 Jun; ():. PubMed ID: 38829270
[No Abstract] [Full Text] [Related]
4. Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
Piris A; Peng Y; Boussahmain C; Essary LR; Gudewicz TM; Hoang MP
Hum Pathol; 2014 Feb; 45(2):320-6. PubMed ID: 24342430
[TBL] [Abstract][Full Text] [Related]
5. GATA3 staining in primary cutaneous apocrine cribriform carcinoma: Usefulness to differentiate it from breast cancer metastasis.
Llamas-Velasco M; Pérez-Gónzalez YC; Daudén E; Rütten A
J Cutan Pathol; 2018 May; 45(5):348-351. PubMed ID: 29431200
[TBL] [Abstract][Full Text] [Related]
6. A Firm Asymptomatic Erythematous Nodule on the Temple.
Estenaga Á; Vallejo RS
Indian J Dermatol; 2021; 66(5):576. PubMed ID: 35068540
[No Abstract] [Full Text] [Related]
7. Adenocarcinoma, Not Otherwise Specified, Arising in Accessory Lacrimal Gland: A Diagnostic Challenge.
Milman T; Iacob C; Lauer S; Feldman MD; Zhang PJL
Ocul Oncol Pathol; 2018 Sep; 4(2):67-72. PubMed ID: 30320083
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.
Compton LA; Murphy GF; Lian CG
Dermatopathology (Basel); 2015; 2(1):15-42. PubMed ID: 27047932
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
[TBL] [Abstract][Full Text] [Related]
10. [Nipple adenoma: report of 18 cases with review of literatures].
Yang GZ; Li J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):614-6. PubMed ID: 20079190
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and morphologic evaluation of primary cutaneous apocrine carcinomas and cutaneous metastases from ductal breast carcinoma.
Fernandez-Flores A
Rom J Morphol Embryol; 2012; 53(4):879-92. PubMed ID: 23303010
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous metastases from breast carcinoma: calretinin expression and estrogen, progesterone and Her2/neu status of the metastases, compared to primary cutaneous apocrine tumors.
Fernandez-Flores A
Rom J Morphol Embryol; 2013; 54(3 Suppl):695-9. PubMed ID: 24322014
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.
Rollins-Raval M; Chivukula M; Tseng GC; Jukic D; Dabbs DJ
Arch Pathol Lab Med; 2011 Aug; 135(8):975-83. PubMed ID: 21809988
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
Steinman S; Wang J; Bourne P; Yang Q; Tang P
Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
